ArticleCellular oncology (Dordrecht, Netherlands)2026
METTL7A inhibits progression of colorectal cancer through the SREBP1 / FDFT1 / SQLE / CYP51A1 / cholesterol metabolic pathway.
Sha Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.